
  
    
      
        Background_NNP
        Rhinoviruses_NNP have_VBP been_VBN associated_VBN with_IN 40_CD %_NN to_TO 65_CD %_NN of_IN
        "_'' common_JJ colds_NNS "_'' studied_VBN by_IN methods_NNS of_IN virus_NN culture_NN [_NN 1_CD 2_CD ]_NN
        ._. With_IN the_DT use_NN of_IN reverse_NN transcriptase_NN -_: polymerase_NN chain_NN
        reaction_NN (_( RT-PCR_NNP )_) ,_, rhinovirus_JJ has_VBZ been_VBN shown_VBN to_TO be_VB
        associated_VBN with_IN 53_CD %_NN of_IN all_DT colds_NNS throughout_IN the_DT year_NN and_CC up_IN
        to_TO 92_CD %_NN of_IN colds_NNS during_IN the_DT autumn_NN outbreak_NN period_NN [_NN 3_CD ]_NN ._.
        Rhinviruses_NNP have_VBP been_VBN implicated_VBN in_IN the_DT exacerbation_NN of_IN
        asthma_NN symptoms_NNS [_NN 4_CD ]_NN and_CC may_MD even_RB play_VB a_DT role_NN in_IN asthma_NN
        related_VBD deaths_NNS [_NN 5_CD ]_NN ._. Due_JJ to_TO their_PRP$ role_NN in_IN the_DT
        exacerbation_NN of_IN asthma_NN symptoms_NNS ,_, rhinoviruses_NNS are_VBP a_DT major_JJ
        cause_NN of_IN pediatric_JJ hospitalizations_NNS [_NN 6_CD ]_NN ._.
        Although_IN rhinoviruses_NNS have_VBP been_VBN thought_VBN to_TO be_VB
        transmitted_VBN via_IN large_JJ droplets_NNS or_CC contact_NN [_NN 7_CD ]_NN ,_, studies_NNS
        in_IN the_DT 1980_CD 's_POS demonstrated_VBN that_IN fomites_NNS are_VBP not_RB an_DT
        effective_JJ means_NNS of_IN transmitting_VBG rhinovirus_JJ infections_NNS [_NN 8_CD 9_CD
        10_CD ]_NN ._. While_IN direct_JJ inoculation_NN of_IN respiratory_JJ secretions_NNS
        has_VBZ been_VBN shown_VBN to_TO transmit_VB infection_NN ,_, this_DT is_VBZ not_RB a_DT likely_JJ
        route_NN of_IN transmission_NN in_IN older_JJR children_NNS and_CC adults_NNS as_IN
        survival_NN on_IN hands_NNS is_VBZ brief_JJ [_NN 9_CD ]_NN ._. Airborne_NNP transmission_NN of_IN
        infection_NN was_VBD clearly_RB demonstrated_VBN in_IN one_CD experimental_JJ
        study_NN on_IN adults_NNS [_NN 8_CD ]_NN ._. However_RB ,_, in_IN the_DT absence_NN of_IN
        epidemiological_JJ studies_NNS designed_VBN to_TO conclusively_RB identify_VB
        modes_NNS of_IN transmission_NN ,_, the_DT role_NN of_IN airborne_JJ transmission_NN in_IN
        viral_JJ respiratory_JJ infection_NN remains_VBZ controversial_JJ ._.
        An_DT impediment_NN to_TO future_JJ studies_NNS of_IN airborne_JJ transmission_NN
        of_IN respiratory_JJ infections_NNS is_VBZ the_DT lack_NN of_IN established_VBN
        methods_NNS for_IN the_DT detection_NN of_IN airborne_JJ respiratory_JJ
        microorganisms_NNS appropriate_JJ for_IN epidemiological_JJ studies_NNS ._.
        Several_JJ laboratory_NN studies_NNS have_VBP been_VBN conducted_VBN in_IN which_WDT
        aerosolized_JJ respiratory_JJ viruses_NNS have_VBP been_VBN collected_VBN and_CC
        quantified_VBN with_IN culture_NN based_VBD methods_NNS [_NN 11_CD 12_CD 13_CD ]_NN ._. These_DT
        studies_NNS were_VBD conducted_VBN to_TO determine_VB the_DT effects_NNS of_IN
        temperature_NN and_CC relative_JJ humidity_NN on_IN the_DT infectivity_NN of_IN
        respiratory_JJ viruses_NNS ,_, but_CC their_PRP$ methods_NNS are_VBP not_RB suitable_JJ for_IN
        the_DT extremely_RB low_JJ concentrations_NNS of_IN virus_NN in_IN field_NN
        experiments_NNS ._. PCR_NNP based_VBD assays_NNS have_VBP been_VBN employed_VBN to_TO detect_VB
        airborne_JJ respiratory_JJ viruses_NNS in_IN a_DT number_NN of_IN small_JJ studies_NNS
        conducted_VBN in_IN hospital_NN rooms_NNS of_IN infected_JJ patients_NNS [_NN 14_CD 15_CD 16_CD
        17_CD ]_NN and_CC in_IN pig_NN houses_NNS [_NN 18_CD ]_NN ._.
        To_TO determine_VB if_IN airborne_JJ microorganisms_NNS can_MD be_VB
        inactivated_JJ ,_, and_CC therefore_RB ,_, prevent_VB infection_NN transmission_NN ,_,
        studies_NNS during_IN the_DT 1940_CD '_POS s-_NN 1970_CD 's_POS used_VBN ultraviolet_NN
        germicidal_NN irradation_NN (_( UVGI_NNP )_) to_TO inactivated_JJ airborne_JJ
        microorganisms_NNS under_IN experimental_JJ conditions_NNS [_NN 19_CD 20_CD 21_CD 22_CD
        ]_NN and_CC reduced_VBN airborne_JJ infections_NNS in_IN a_DT number_NN of_IN settings_NNS ,_,
        such_JJ as_IN hospitals_NNS [_NN 23_CD ]_NN ,_, military_JJ housing_NN [_NN 24_CD ]_NN ,_, and_CC
        classrooms_NNS [_NN 25_CD ]_NN ._. However_RB ,_, UVGI_NNP was_VBD not_RB effective_JJ against_IN
        the_DT highly_RB contagious_JJ measles_NNS virus_NN when_WRB children_NNS had_VBD
        extensive_JJ contact_NN in_IN buses_NNS and_CC crowded_VBN tenements_NNS [_NN 26_CD 27_CD ]_NN
        ._. Thus_RB ,_, it_PRP fell_VBD into_IN disfavor_NN and_CC has_VBZ not_RB been_VBN extensively_RB
        employed_VBN nor_CC has_VBZ it_PRP been_VBN studied_VBN using_VBG molecular_JJ methods_NNS of_IN
        detecting_VBG its_PRP$ efficacy_NN ._.
        Because_IN we_PRP anticipate_VBP future_JJ studies_NNS of_IN UVGI_NNP will_MD use_VB
        PCR_NNP based_VBD detection_NN methods_NNS ,_, it_PRP is_VBZ important_JJ to_TO determine_VB
        how_WRB PCR_NNP assays_NNS react_VBP to_TO UVGI_NNP damaged_VBD genetic_JJ material_NN ._. In_IN
        DNA_NNP ,_, UVGI_NNP predominately_RB produces_VBZ damage_NN in_IN the_DT form_NN of_IN
        cyclobutylpyrimidine_NN dimers_NNS and_CC (_( 6_CD -_: 4_LS )_) photoproducts_NNS ._. These_DT
        photoproducts_NNS disrupt_VB the_DT replication_NN of_IN the_DT genetic_JJ
        material_NN and_CC ,_, therefore_RB ,_, inhibit_VBP the_DT replication_NN ._. There_EX is_VBZ
        limited_VBN information_NN regarding_VBG the_DT effect_NN of_IN UVGI_NNP on_IN RNA_NNP ._.
        There_EX are_VBP conflicting_JJ studies_NNS on_IN viruses_NNS with_IN RNA_NNP genomes_NNS
        that_WDT have_VBP attempted_VBN to_TO determine_VB if_IN PCR_NNP assays_NNS are_VBP
        inhibited_VBD by_IN UVGI_NNP ._. Two_CD studies_NNS involving_VBG hepatitis_NN A_DT virus_NN
        (_( single-stranded_JJ positive_JJ sense_NN RNA_NNP genome_NN )_) and_CC rotavirus_JJ
        (_( double-stranded_JJ RNA_NNP genome_NN )_) ,_, showed_VBD their_PRP$ PCR_NNP assays_NNS to_TO be_VB
        inhibited_VBD by_IN UV_NNP inactivation_NN of_IN the_DT viruses_NNS [_NN 28_CD 29_CD ]_NN ._.
        Conversely_RB ,_, Ma_NNP et_CC al_NN showed_VBD no_DT effect_NN of_IN UV_NNP on_IN a_DT PCR_NNP assay_NN
        when_WRB they_PRP irradiated_JJ poliovirus_JJ (_( single-stranded_JJ positive_JJ
        sense_NN RNA_NNP genome_NN )_) [_NN 30_CD ]_NN ._. In_IN this_DT study_NN ,_, we_PRP present_VB an_DT
        extremely_RB sensitive_JJ PCR_NNP based_VBD assay_NN to_TO detect_VB airborne_JJ
        rhinovirus_JJ and_CC demonstrate_VB the_DT effect_NN of_IN ultraviolet_NN
        irradiation_NN on_IN the_DT assay_NN ._.
      
      
        Methods_NNP
        
          Organism_NNP
          We_PRP obtained_VBD rhinovirus_JJ 16_CD strain_NN 11757_CD from_IN ATCC_NNP
          (_( Manassas_NNP ,_, Virginia_NNP )_) with_IN a_DT titer_NN of_IN 10_CD 7_CD ._. 25_CD particles_NNS per_IN
          0_CD ._. 2_CD ml_NN ._. The_DT suspension_NN was_VBD diluted_VBN with_IN phosphate_NN
          buffered_JJ saline_NN (_( PBS_NNP )_) to_TO create_VB four_CD different_JJ
          concentrations_NNS to_TO be_VB used_VBN in_IN the_DT experiment_NN ._.
        
        
          Aerosolization_NNP and_CC chamber_NN description_NN
          We_PRP generated_VBD a_DT rhinoviral_NN aerosol_NN with_IN a_DT 6_CD -_: jet_NN
          Collison_NNP nebulizer_NN (_( model_NN CN-_NNP 38_CD ,_, BGI_NNP ,_, Waltham_NNP ,_, MA_NNP )_) ,_, which_WDT
          generates_VBZ 2_CD -_: μm_NN mass-median_JJ diameter_NN (_( MMD_NNP )_) droplets_NNS when_WRB
          run_VB at_IN 20_CD psig_NN of_IN air_NN pressure_NN [_NN 31_CD ]_NN ._. The_DT nebulizing_VBG
          solution_NN consists_VBZ of_IN PBS_NNP ,_, diluted_VBN virus_NN ,_, and_CC 0_CD ._. 05_CD g_SYM /_NN l_NN
          uranine_NN ._. We_PRP used_VBD the_DT uranine_NN as_IN a_DT fluorescent_NN tracer_NN ,_, so_IN
          that_IN some_DT filters_NNS could_MD be_VB used_VBN to_TO determine_VB the_DT
          percentage_NN of_IN actual_JJ collection_NN versus_CC theoretical_JJ
          collection_NN ._. The_DT aerosol_NN was_VBD generated_VBN in_IN a_DT specially_RB
          designed_VBN aerosolization_NN chamber_NN that_WDT had_VBD been_VBN used_VBN in_IN
          studies_NNS of_IN UV_NNP sensitivity_NN of_IN 
          Serratia_NNP marcescens_NNS and_CC bacilli_NN
          Calmette-_NNP Guérin_NNP (_( Figure_NN 1_LS )_) [_NN 32_CD ]_NN ._.
          The_DT chamber_NN consists_VBZ of_IN four_CD parts_NNS :_: a_DT drying_VBG jar_NN ,_, a_DT
          165_CD mm_NN square_JJ duct_NN where_WRB the_DT aerosol_NN first_RB enters_VBZ the_DT
          chamber_NN ,_, a_DT UV_NNP exposure_NN chamber_NN ,_, and_CC sampling_VBG ports_NNS ._. We_PRP
          attached_VBD a_DT Collison_NNP nebulizer_NN to_TO the_DT drying_VBG jar_NN ,_, where_WRB
          the_DT aerosol_NN is_VBZ given_VBN time_NN to_TO dry_VB ,_, before_IN entering_VBG the_DT
          square_JJ duct_NN through_IN a_DT 9_CD -_: port_NN manifold_NN ,_, which_WDT creates_VBZ a_DT
          uniformly_RB distributed_VBN aerosol_NN ._. The_DT aerosol_NN next_JJ enters_VBZ
          the_DT UV_NNP exposure_NN chamber_NN ._. The_DT UV_NNP exposure_NN chamber_NN is_VBZ
          comprised_VBN of_IN a_DT fused_JJ quartz_NN UV_NNP exposure_NN window_NN (_( 279_CD ×_NN 254_CD
          mm_NN )_) ,_, on_IN which_WDT a_DT UV_NNP fixture_NN containing_VBG six_CD 36_CD -_: watt_NN UV_NNP
          lamps_NNS (_( Lumalier_NNP ,_, Memphis_NNP ,_, Tennessee_NNP )_) sits_VBZ ._. We_PRP inserted_VBD
          two_CD types_NNS of_IN screens_NNS beneath_IN the_DT UV_NNP fixture_NN to_TO adjust_VB the_DT
          level_NN of_IN irradiance_NN ._. Downstream_NNP of_IN the_DT exposure_NN chamber_NN a_DT
          slide_NN contains_VBZ three_CD ports_NNS ._. One_CD port_NN is_VBZ used_VBN to_TO collect_VB
          the_DT aerosol_NN sample_NN with_IN our_PRP$ sampling_VBG filters_NNS (_( Teflo_NNP 2_CD ._. 0_CD
          μm_NN pore_NN ,_, Pall_NNP Gelman_NNP ,_, Ann_NNP Arbor_NNP ,_, Michigan_NNP )_) mounted_VBD in_IN
          filter_NN cassettes_NNS (_( Millipore_NNP Corp_NNP ._. ,_, Bedford_NNP ,_,
          Massachusetts_NNP )_) while_IN the_DT other_JJ ports_NNS can_MD be_VB loaded_VBN with_IN
          two_CD Teflo_NNP filters_NNS in_IN series_NN ,_, to_TO allow_VB a_DT bypass_NN while_IN
          changing_VBG sampling_VBG filters_NNS ._. Two_CD filters_NNS were_VBD used_VBN in_IN the_DT
          bypass_NN to_TO ensure_VB that_IN no_DT aerosol_NN escaped_VBD the_DT chamber_NN ._. The_DT
          multiple_JJ ports_NNS allow_VBP changing_NN of_IN filters_NNS without_IN
          interrupting_VBG the_DT aerosol_NN flow_NN ._. Makeup_NNP air_NN passes_VBZ through_IN
          a_DT Teflon_NNP filter_NN prior_RB to_TO entering_VBG the_DT chamber_NN to_TO prevent_VB
          environmental_JJ microorganisms_NNS from_IN entering_VBG the_DT
          chamber_NN ._.
          Filtered_VBN air_NN was_VBD pumped_VBN through_IN the_DT chamber_NN at_IN a_DT rate_NN
          of_IN 8_CD ._. 5_CD l_NN /_NN min_NN monitored_VBN by_IN a_DT rotameter_NN ._. To_TO provide_VB
          additional_JJ protection_NN ,_, the_DT experimental_JJ chamber_NN was_VBD
          housed_VBN within_IN a_DT Class_NNP II_NNP ,_, Type_NNP A_DT biosafety_NN cabinet_NN ._.
          Although_IN temperature_NN and_CC %_NN RH_NNP were_VBD not_RB controlled_VBN ,_, they_PRP
          were_VBD measured_VBN with_IN continuous_JJ monitors_VBZ (_( HOBO_NNP H_NNP 08_CD -_: 004_CD -_: 02_CD
          four_CD channel_NN data_NNS loggers_NNS ,_, Onset_NNP Computer_NNP Corp_NNP ._. ,_, Bourne_NNP ,_,
          Massachusetts_NNP )_) downstream_JJ of_IN the_DT sampling_VBG filters_NNS ._.
        
        
          Aerosol_NNP procedures_NNS
          Airflow_NNP through_IN the_DT chamber_NN was_VBD maintained_VBN at_IN 8_CD ._. 5_CD
          l_NN /_NN min_NN for_IN 10_CD minutes_NNS ._. We_PRP then_RB began_VBD the_DT aerosolization_NN of_IN
          the_DT rhinoviral_NN solution_NN and_CC allowed_VBD the_DT aerosol_NN to_TO flow_VB
          through_IN the_DT bypass_NN filter_NN for_IN 20_CD minutes_NNS ._. Air_NN samples_NNS
          were_VBD then_RB collected_VBN for_IN 10_CD minutes_NNS ._. For_IN sampling_VBG runs_VBZ
          that_WDT included_JJ testing_VBG for_IN effects_NNS of_IN UV_NNP exposure_NN ,_, the_DT UV_NNP
          radiation_NN was_VBD turned_VBN on_IN and_CC allowed_VBN to_TO warm_VB up_RP for_IN 10_CD
          minutes_NNS while_IN airflow_NN was_VBD directed_VBN through_IN the_DT bypass_NN
          filter_NN ._. An_DT air_NN sample_NN was_VBD then_RB collected_VBN for_IN 10_CD minutes_NNS ._.
          Three_CD replicates_NNS of_IN UV_NNP exposed_VBD and_CC nonexposed_JJ particle_NN
          samples_NNS were_VBD collected_VBN during_IN each_DT sampling_VBG run_NN ._. Aerosols_NNP
          were_VBD exposed_VBN to_TO an_DT irradiance_NN level_NN of_IN 30_CD mW_NN /_NN m_NN 2_CD for_IN 22_CD ._. 8_CD
          s_VBZ for_IN a_DT UV_NNP dose_NN of_IN 684_CD mJ_NN /_NN m_NN 2_CD ._.
        
        
          Spiking_NNP experiments_NNS
          Prior_RB to_TO the_DT aerosol_NN experiments_NNS ,_, we_PRP spiked_VBN filters_NNS
          with_IN progressively_RB more_JJR dilute_VB viral_JJ suspensions_NNS to_TO
          determine_VB the_DT limit_NN of_IN detection_NN of_IN our_PRP$ extraction_NN and_CC
          semi-nested_JJ RT-PCR_NNP assay_NN ._. For_IN spiking_VBG ,_, 1_CD μl_NN methanol_NN was_VBD
          placed_VBN on_IN the_DT filter_NN as_IN a_DT wetting_VBG agent_NN followed_VBN by_IN 1_CD μl_NN
          of_IN diluted_VBN virus_NN ._. Filters_NNP were_VBD and_CC allowed_VBN to_TO dry_VB prior_RB
          to_TO extraction_NN ._. We_PRP also_RB spiked_JJ one_CD filter_NN prior_RB to_TO each_DT
          aerosol_NN chamber_NN run_NN as_IN a_DT positive_JJ control_NN ._. To_TO test_VB the_DT
          stability_NN of_IN virus_NN on_IN the_DT filters_NNS ,_, a_DT test_NN was_VBD conducted_VBN
          in_IN which_WDT spiked_JJ filters_NNS were_VBD used_VBN to_TO collect_VB air_NN samples_NNS
          for_IN one_CD week_NN in_IN our_PRP$ laboratory_NN ,_, which_WDT has_VBZ single_JJ pass_NN air_NN
          and_CC is_VBZ therefore_RB an_DT unlikely_JJ source_NN of_IN rhinovirus_JJ ._.
        
        
          Filter_NNP extraction_NN
          We_PRP placed_VBD the_DT filters_NNS face_VBP down_RB in_IN a_DT 60_CD mm_NN petri_NN dish_NN
          using_VBG sterile_JJ forceps_NNS ._. We_PRP then_RB added_VBD 560_CD μl_NN of_IN prepared_VBN
          AVL_NNP buffer_NN containing_VBG carrier_NN RNA_NNP (_( Qiagen_NNP QIAamp_NNP Viral_NNP
          RNA_NNP Mini_NNP Kit_NNP )_) and_CC 140_CD μl_NN phosphate_NN buffered_JJ saline_NN (_( PBS_NNP )_) ._.
          After_IN placing_VBG the_DT lids_NNS on_IN the_DT dishes_NNS ,_, the_DT dishes_NNS were_VBD
          secured_VBN to_TO an_DT orbital_NN tabletop_NN shaker_NN (_( VWR_NNP Scientific_NNP
          Products_NNPS ,_, Thorofare_NNP ,_, New_NNP Jersey_NNP )_) and_CC rotated_VBD for_IN 20_CD
          minutes_NNS at_IN 360_CD RPM_NNP ._. After_IN shaking_VBG ,_, we_PRP pipeted_JJ the_DT eluted_JJ
          material_NN from_IN the_DT petri_NN dish_NN into_IN a_DT sterile_JJ microfuge_NN
          tube_NN ._.
        
        
          RNA_NNP extraction_NN
          We_PRP extracted_VBD the_DT RNA_NNP from_IN the_DT filter_NN samples_NNS with_IN the_DT
          Qiagen_NNP QIAamp_NNP Viral_NNP RNA_NNP Mini_NNP Kit_NNP following_VBG manufacturer_NN 's_POS
          protocol_NN ._. The_DT use_NN of_IN the_DT Qiagen_NNP QIAamp_NNP Viral_NNP RNA_NNP Mini_NNP Kit_NNP
          resulted_VBD in_IN 80_CD μl_NN of_IN purified_JJ viral_JJ RNA_NNP ._.
        
        
          Semi-nested_NNP RT-PCR_NNP amplification_NN
          Following_VBG extraction_NN ,_, we_PRP first_RB amplified_VBN the_DT
          picornavirus_JJ RNA_NNP using_VBG primers_NNS OL_NNP 26_CD (_( 5_CD '_POS -_: GCA_NNP CTT_NNP CTG_NNP TTT_NNP
          CCC_NNP C-_NNP 3_CD '_POS )_) [_NN 33_CD ]_NN and_CC OL_NNP 27_CD (_( 5_CD '_POS -_: CGG_NNP ACA_NNP CCC_NNP AAA_NNP GTA_NNP G-_NNP 3_CD '_POS )_) [_NN
          33_CD ]_NN using_VBG the_DT Invitrogen_NNP SuperScript_NNP One-_NNP Step_NN RT-PCR_NNP
          with_IN PLATINUM_NNP 
          Taq_NNP Kit_NNP (_( Invitrogen_NNP Corp_NNP ._. ,_,
          Carlsbad_NNP ,_, California_NNP )_) ._. The_DT PCR_NNP mixture_NN contained_VBD 2_CD ×_NN
          reaction_NN buffer_NN (_( 0_CD ._. 4_LS mM_NN of_IN each_DT dNTP_NN ,_, 2_CD ._. 4_CD mM_NN MgSO_NNP 
          4_LS )_) ,_, 1_CD μl_NN of_IN each_DT primer_NN (_( 0_CD ._. 2_LS μM_NN )_) ,_, 1_CD
          μl_NN RT_NNP /_NN PLATINUM_NNP 
          Taq_NNP Mix_NNP and_CC 10_CD μl_NN of_IN the_DT RNA_NNP
          template_NN in_IN a_DT final_JJ volume_NN of_IN 50_CD μl_NN ._. We_PRP conducted_VBD the_DT PCR_NNP
          reaction_NN in_IN a_DT MJ_NNP Research_NNP (_( Watertown_NNP ,_, Massachusetts_NNP )_)
          PTC-_NNP 200_CD Peltier_NNP Thermal_JJ Cycler_NNP programmed_VBN with_IN an_DT initial_JJ
          cDNA_NN synthesis_NN and_CC pre-denaturation_JJ step_NN of_IN 50_CD °_NN C_NNP for_IN 30_CD
          minutes_NNS and_CC 94_CD °_NN C_NNP for_IN 2_CD minutes_NNS followed_VBN by_IN then_RB 36_CD cycles_NNS
          of_IN denature_NN ,_, annealing_VBG and_CC extension_NN (_( 15_CD s_VBZ at_IN 94_CD °_NN C_NNP ,_, 30_CD s_VBZ
          at_IN 55_CD °_NN C_NNP ,_, 30_CD s_VBZ at_IN 68_CD °_NN C_NNP )_) ._.
          We_PRP then_RB amplified_VBN the_DT PCR_NNP products_NNS from_IN the_DT RT-PCR_NNP
          step_NN using_VBG primers_NNS OL_NNP 26_CD (_( 5_CD '_POS -_: GCA_NNP CTT_NNP CTG_NNP TTT_NNP CCC_NNP C-_NNP 3_CD '_POS )_) and_CC
          JWA-_NNP 1_CD b_SYM (_( 5_CD '_POS -_: CAT_NNP TCA_NNP GGG_NNP GCC_NNP GGA_NNP GGA-_NNP 3_CD '_POS )_) [_NN 34_CD ]_NN ._. The_DT PCR_NNP
          mixture_NN contained_VBD 2_CD ×_NN reaction_NN buffer_NN (_( 0_CD ._. 4_LS mM_NN of_IN each_DT
          dNTP_NN ,_, 2_CD ._. 4_CD mM_NN MgSO_NNP 
          4_LS )_) ,_, 1_CD μl_NN of_IN each_DT primer_NN (_( 0_CD ._. 2_LS μM_NN )_) ,_,
          0_CD ._. 25_CD μl_NN AmpliTaq_NNP (_( Applied_NNP Biosystems_NNP ,_, Foster_NNP City_NNP ,_,
          California_NNP )_) and_CC 10_CD μl_NN of_IN RT-PCR_NNP product_NN in_IN a_DT final_JJ volume_NN
          of_IN 50_CD μl_NN ._. We_PRP conducted_VBD the_DT PCR_NNP reaction_NN for_IN 36_CD cycles_NNS of_IN
          denature_NN ,_, annealing_VBG and_CC extension_NN (_( 15_CD s_VBZ at_IN 94_CD °_NN C_NNP ,_, 30_CD s_VBZ at_IN
          55_CD °_NN C_NNP ,_, 30_CD s_VBZ at_IN 68_CD °_NN C_NNP )_) ,_, followed_VBN by_IN a_DT final_JJ extension_NN of_IN 4_CD
          min_NN at_IN 72_CD °_NN C_NNP ._.
        
        
          Gel_NNP electrophoresis_NNS
          Amplified_NNP products_NNS were_VBD detected_VBN by_IN electrophoresis_NNS
          analysis_NN on_IN 2_CD %_NN agarose_NN gel_NN containing_VBG 8_CD μl_NN of_IN ethidium_NN
          bromide_NN per_IN 200_CD ml_NN of_IN gel_NN followed_VBN by_IN examination_NN under_IN
          UV_NNP light_NN ._.
        
        
          PCR_NNP products_NNS
          The_DT OL_NNP 26_CD and_CC OL_NNP 27_CD primer_NN pair_NN generates_VBZ a_DT 388_CD base_NN
          pair_NN amplicon_NN from_IN a_DT region_NN of_IN the_DT 5_CD '_POS noncoding_VBG region_NN of_IN
          the_DT picornavirus_JJ genome_NN ._. The_DT semi-nested_JJ primer_NN pair_NN of_IN
          OL_NNP 26_CD and_CC JWA-_NNP 1_CD b_SYM generates_VBZ an_DT amplicon_NN of_IN ~_NN 292_CD base_NN pairs_NNS
          from_IN within_IN the_DT original_JJ amplicon_NN ._. The_DT 292_CD bp_NN amplicon_NN
          does_VBZ not_RB differentiate_VB between_IN rhinovirus_JJ and_CC enterovirus_JJ
          [_NN 34_CD ]_NN ._.
        
        
          Uranine_NNP analysis_NN
          Uranine_NNP was_VBD used_VBN as_IN a_DT fluorescent_NN tracer_NN ,_, which_WDT
          allowed_VBD us_PRP to_TO determine_VB a_DT percent_NN yield_NN for_IN each_DT sampling_VBG
          run_NN ._. To_TO determine_VB the_DT amount_NN of_IN aerosol_NN collected_VBN on_IN each_DT
          filter_NN ,_, uranine_NN analysis_NN was_VBD conducted_VBN on_IN three_CD filters_NNS
          per_IN sampling_VBG run_NN ,_, one_CD each_DT from_IN the_DT beginning_NN ,_, middle_NN and_CC
          end_NN of_IN each_DT run_NN ._. The_DT filters_NNS used_VBN for_IN uranine_NN analysis_NN
          were_VBD removed_VBN from_IN cassette_NN holders_NNS and_CC placed_VBN into_IN a_DT 100_CD
          mm_NN test_NN tube_NN with_IN sterile_JJ forceps_NNS ._. We_PRP added_VBD 5_CD ml_NN of_IN PBS_NNP
          to_TO each_DT tube_NN and_CC sonicated_JJ for_IN an_DT hour_NN with_IN vortexing_VBG
          every_DT 15_CD minutes_NNS ._. We_PRP also_RB collected_VBD samples_NNS of_IN the_DT
          nebulizing_VBG fluid_JJ before_IN and_CC after_IN nebulization_NN ._. Filter_NNP
          samples_NNS and_CC nebulizing_VBG fluid_JJ samples_NNS were_VBD diluted_VBN with_IN
          0_CD ._. 01_CD N_NNP NaOH_NNP and_CC analyzed_VBD with_IN a_DT spectrofluorometer_NN
          (_( excitation_NN 485_CD nm_NN and_CC emission_NN 535_CD nm_NN )_) (_( Tecan_NNP Corp_NNP ._.
          Spectrafluor_NNP Plus_NNP ,_, Mannedorf_NNP ,_, Switzerland_NNP )_) ._. We_PRP averaged_VBD
          the_DT results_NNS of_IN the_DT three_CD filters_NNS to_TO calculate_VB an_DT
          estimated_VBN percent_NN yield_NN for_IN the_DT sampling_VBG run_NN ._.
        
        
          Data_NNP analysis_NN
          The_DT amount_NN of_IN uranine_NN nebulized_JJ during_IN each_DT sampling_VBG
          run_NN was_VBD determined_VBN by_IN measuring_VBG the_DT amount_NN of_IN fluid_JJ
          consumed_VBN and_CC by_IN measuring_VBG the_DT fluorescence_NN of_IN nebulizing_VBG
          fluid_JJ before_IN and_CC after_IN each_DT sampling_VBG run_NN ._. Using_VBG the_DT total_JJ
          aerosolization_NN time_NN during_IN the_DT sampling_VBG run_NN ,_, we_PRP
          determined_VBD the_DT amount_NN of_IN uranine_NN that_IN theoretically_RB would_MD
          be_VB on_IN each_DT filter_NN if_IN we_PRP collected_VBD 100_CD %_NN of_IN the_DT aerosol_NN
          generated_VBN during_IN the_DT 10_CD -_: minute_NN exposure_NN of_IN each_DT filter_NN ._.
          Using_VBG the_DT filter_NN samples_NNS that_WDT were_VBD analyzed_VBN for_IN uranine_NN ,_,
          we_PRP determined_VBD the_DT actual_JJ amount_NN of_IN uranine_NN collected_VBN per_IN
          sample_NN ._. We_PRP averaged_VBD the_DT three_CD filter_NN samples_NNS per_IN run_NN and_CC
          divided_VBN by_IN the_DT total_JJ amount_NN of_IN uranine_NN consumed_VBN to_TO
          determine_VB a_DT percent_NN yield_NN (_( observed_VBD /_NN expected_VBN )_) for_IN the_DT
          sampling_VBG run_NN ._.
          We_PRP computed_JJ the_DT expected_VBN number_NN of_IN TCID_NNP 
          50_CD on_IN each_DT filter_NN sample_NN from_IN the_DT
          known_VBN TCID_NNP 
          50_CD and_CC fluid_JJ volume_NN added_VBD to_TO the_DT
          nebulizer_NN ,_, the_DT amount_NN of_IN nebulizing_VBG fluid_JJ consumed_VBN per_IN
          minute_NN ,_, and_CC the_DT sampling_VBG time_NN ._. The_DT expected_VBN TCID_NNP 
          50_CD was_VBD adjusted_VBN for_IN the_DT yield_NN for_IN the_DT
          uranine_NN samples_NNS ._.
        
      
      
        Results_NNS
        We_PRP were_VBD able_JJ to_TO obtain_VB from_IN the_DT dilution_NN gradient_NN filter_NN
        spiking_VBG experiments_NNS a_DT positive_JJ band_NN from_IN a_DT 1_CD :_: 500_CD ,_, 000_CD
        dilution_NN of_IN virus_NN ,_, which_WDT translates_NNS into_IN a_DT detected_VBN amount_NN
        of_IN approximately_RB 0_CD ._. 77_CD TCID_NNP 
        50_CD or_CC 0_CD ._. 39_CD PFU_NNP 's_POS per_IN filter_NN ._. The_DT
        stability_NN tests_NNS ,_, in_IN which_WDT ,_, filters_NNS spiked_VBN with_IN 25_CD TCID_NNP 
        50_CD /_NN filter_NN were_VBD used_VBN to_TO collect_VB air_NN
        samples_NNS for_IN 40_CD hours_NNS did_VBD not_RB display_VB any_DT difference_NN in_IN band_NN
        strength_NN compared_VBN to_TO control_VB filters_NNS ._. Figure_NN 2_CD displays_NNS the_DT
        results_NNS from_IN the_DT aerosol_NN experiments_NNS with_IN the_DT lowest_JJS
        concentration_NN of_IN virus_NN detected_VBD ._.
        Table_NNP 1_CD summarizes_NNS results_NNS of_IN the_DT aerosol_NN experiments_NNS ,_,
        including_VBG the_DT expected_VBN TCID_NNP 
        50_CD captured_VBN on_IN each_DT filter_NN during_IN each_DT
        sampling_VBG run_NN and_CC the_DT number_NN of_IN filters_NNS that_WDT produced_VBD
        positive_JJ RT-PCR_NNP results_NNS ._. The_DT limit_NN of_IN detection_NN of_IN our_PRP$
        semi-nested_JJ RT-PCR_NNP assay_NN with_IN primers_NNS OL_NNP 26_CD ,_, OL_NNP 27_CD and_CC JWA-_NNP 1_CD b_SYM
        is_VBZ in_IN the_DT range_NN of_IN 1_CD ._. 3_CD TCID_NNP 
        50_CD /_NN filter_NN ,_, yielding_VBG a_DT clearly_RB visible_JJ
        292_CD bp_NN band_NN ._. No_DT signal_NN was_VBD detected_VBN from_IN samples_NNS with_IN 0_CD ._. 5_CD
        TCID_NNP 
        50_CD /_NN filter_NN ._. The_DT percent_NN yields_NNS for_IN each_DT
        sampling_VBG run_NN ,_, were_VBD low_JJ ,_, ranging_VBG from_IN 4_CD %_NN to_TO 10_CD %_NN ._. Temperature_NNP
        and_CC relative_JJ humidity_NN were_VBD recorded_VBN in_IN the_DT air_NN downstream_JJ
        of_IN the_DT chamber_NN ._. The_DT average_JJ temperature_NN inside_IN the_DT chamber_NN
        was_VBD very_RB consistent_JJ ,_, ranging_VBG from_IN 26_CD ._. 4_LS °_NN C_NNP to_TO 27_CD °_NN C_NNP and_CC the_DT
        %_JJ RH_NNP ranged_VBD from_IN 24_CD ._. 9_CD to_TO 50_CD ._. 7_CD ._.
        Figure_NN 3_CD shows_VBZ the_DT results_NNS from_IN test_NN of_IN the_DT effect_NN of_IN UV_NNP
        exposure_NN on_IN aerosolized_JJ rhinovirus_JJ ._. Lanes_NNP 5_CD and_CC 6_CD contain_VB
        PCR_NNP products_NNS from_IN filters_NNS containing_VBG UV_NNP exposed_VBD aerosol_NN ._. No_DT
        difference_NN was_VBD detected_VBN between_IN the_DT UV_NNP exposed_VBD and_CC
        nonexposed_JJ filter_NN samples_NNS ._.
        In_IN order_NN to_TO determine_VB if_IN the_DT uranine_NN in_IN the_DT viral_JJ
        suspension_NN was_VBD inhibiting_VBG the_DT extraction_NN and_CC detection_NN
        assay_NN ,_, two_CD otherwise_RB identical_JJ runs_NNS were_VBD conducted_VBN -_: one_CD
        with_IN and_CC one_CD without_IN uranine_NN ._. Each_DT sampling_VBG run_NN was_VBD
        conducted_VBN with_IN nebulizing_VBG solution_NN containing_VBG 10_CD ._. 1_LS TCID_NNP 
        50_CD per_IN ml_NN ._. Results_NNS of_IN the_DT two_CD runs_NNS were_VBD
        identical_JJ ,_, demonstrating_VBG that_IN the_DT uranine_NN was_VBD not_RB
        inhibitory_NN to_TO the_DT extraction_NN or_CC RT-PCR_NNP assay_NN ._.
      
      
        Discussion_NNP
        The_DT majority_NN of_IN rhinoviral_NN transmission_NN among_IN adults_NNS is_VBZ
        thought_VBN to_TO occur_VB via_IN airborne_JJ infectious_JJ droplet_NN nuclei_NN [_NN 8_CD
        9_CD 10_CD ]_NN ._. This_DT study_NN was_VBD conducted_VBN to_TO assess_VB the_DT ability_NN to_TO
        detect_VB airborne_JJ rhinovirus_JJ on_IN air_NN sampling_VBG filters_NNS and_CC
        documents_VBZ the_DT first_JJ successful_JJ attempt_NN to_TO detect_VB airborne_JJ
        rhinovirus_JJ using_VBG RT-PCR_NNP amplification-based_JJ techniques_NNS ._.
        These_DT techniques_NNS allow_VBP for_IN a_DT highly_RB sensitive_JJ method_NN to_TO
        conduct_VB air_NN sampling_VBG for_IN rhinovirus_JJ ._. This_DT assay_NN also_RB is_VBZ
        capable_JJ of_IN detecting_VBG aerosolized_JJ enterovirus_JJ ,_, although_IN
        future_JJ studies_NNS are_VBP necessary_JJ to_TO confirm_VB the_DT limit_NN of_IN
        detection_NN for_IN enteroviral_NN aerosols_NNS
        Our_PRP$ limit_NN of_IN detection_NN for_IN the_DT collection_NN ,_, extraction_NN
        and_CC amplification_NN of_IN aerosolized_JJ rhinovirus_JJ was_VBD 1_CD ._. 3_CD TCID_NNP 
        50_CD ._. The_DT spiking_VBG experiments_NNS we_PRP
        conducted_VBD had_VBD a_DT limit_NN of_IN detection_NN of_IN approximately_RB 0_CD ._. 8_CD
        TCID_NNP 
        50_CD or_CC 60_CD %_NN of_IN what_WP was_VBD detected_VBN when_WRB the_DT
        virus_NN was_VBD aerosolized_JJ ._. These_DT results_NNS can_MD be_VB interpreted_VBN in_IN
        several_JJ ways_NNS ._. One_CD possibility_NN is_VBZ that_IN the_DT virus_NN may_MD be_VB
        damaged_VBN during_IN the_DT process_NN of_IN aerosolization_NN in_IN the_DT
        Collison_NNP nebulizer_NN ,_, and_CC that_IN the_DT RNA_NNP from_IN the_DT damaged_VBN virus_NN
        cannot_NN be_VB amplified_VBN ._. This_DT explanation_NN would_MD account_VB for_IN the_DT
        results_NNS shown_VBN in_IN Figure_NN 2_CD where_WRB the_DT nebulization_NN solution_NN
        prior_RB to_TO aerosolization_NN yielded_VBD a_DT positive_JJ result_NN while_IN
        after_IN aerosolization_NN we_PRP obtained_VBD a_DT negative_JJ result_NN ._. Another_DT
        possible_JJ explanation_NN is_VBZ that_IN it_PRP is_VBZ easier_JJR to_TO extract_VB the_DT
        virus_NN from_IN a_DT dried_VBN liquid_JJ droplet_NN ,_, as_IN was_VBD done_VBN in_IN the_DT
        spiking_VBG experiments_NNS ,_, than_IN from_IN an_DT aerosol_NN spread_VBD uniformly_RB
        over_IN the_DT filter_NN surface_NN ._.
        We_PRP were_VBD unable_JJ to_TO recover_VB the_DT majority_NN of_IN aerosol_NN that_WDT
        was_VBD expelled_VBN into_IN the_DT chamber_NN ._. The_DT main_JJ reason_NN for_IN the_DT low_JJ
        yields_NNS appears_VBZ to_TO be_VB the_DT result_NN of_IN large_JJ droplets_NNS falling_VBG
        out_IN in_IN the_DT drying_VBG jar_NN prior_RB to_TO entry_NN into_IN the_DT exposure_NN
        chamber_NN ._. Because_IN the_DT yields_NNS were_VBD the_DT same_JJ regardless_RB of_IN the_DT
        UV_NNP status_NN ,_, the_DT low_JJ yields_NNS should_MD not_RB affect_VB our_PRP$
        results_NNS ._.
        Previous_JJ studies_NNS have_VBP shown_VBN that_IN UV_NNP inhibits_NNS PCR_NNP assays_NNS
        in_IN single_JJ and_CC double_RB stranded_VBN RNA_NNP viruses_NNS ,_, [_NN 28_CD 29_CD ]_NN while_IN
        our_PRP$ RT-PCR_NNP method_NN did_VBD not_RB detect_VB a_DT difference_NN between_IN UV_NNP
        exposed_VBD and_CC nonexposed_JJ rhinoviral_NN aerosols_NNS ._. The_DT most_RBS likely_JJ
        reason_NN for_IN this_DT is_VBZ a_DT matter_NN of_IN dose_NN ,_, although_IN it_PRP is_VBZ
        possible_JJ that_IN characteristics_NNS of_IN the_DT particular_JJ viruses_NNS and_CC
        PCR_NNP methods_NNS could_MD also_RB explain_VB the_DT results_NNS ._. Neither_DT of_IN the_DT
        previous_JJ studies_NNS were_VBD conducted_VBN on_IN aerosolized_JJ virus_NN and_CC
        the_DT dose_NN of_IN UV_NNP was_VBD several_JJ orders_NNS of_IN magnitude_NN greater_JJR ._.
        This_DT study_NN ,_, did_VBD not_RB determine_VB whether_IN the_DT rhinovirus_JJ
        aerosol_NN was_VBD capable_JJ of_IN infection_NN after_IN exposure_NN to_TO the_DT high_JJ
        UV_NNP dose_NN used_VBN in_IN these_DT experiments_NNS ._. It_PRP is_VBZ possible_JJ that_IN the_DT
        UV_NNP irradiation_NN damaged_VBD other_JJ regions_NNS of_IN the_DT viral_JJ RNA_NNP and_CC
        not_RB the_DT region_NN that_IN our_PRP$ primers_NNS amplified_VBN ,_, or_CC that_IN the_DT
        amount_NN of_IN damage_NN required_VBN to_TO prevent_VB RT-PCR_NNP amplification_NN
        is_VBZ greater_JJR than_IN the_DT amount_NN of_IN damage_NN sufficient_JJ to_TO prevent_VB
        infection_NN ._. This_DT suggests_VBZ possible_JJ future_JJ studies_NNS to_TO
        investigate_VB the_DT relationship_NN between_IN UV_NNP damage_NN ,_,
        infectiousness_NNS ,_, and_CC detection_NN by_IN RT-PCR_NNP of_IN various_JJ regions_NNS
        of_IN the_DT rhinovirus_JJ genome_NN ._.
        The_DT limit_NN of_IN detection_NN of_IN our_PRP$ assay_NN must_MD be_VB put_VBN into_IN
        context_NN with_IN the_DT amount_NN of_IN virus_NN shed_VBN by_IN an_DT infectious_JJ
        individual_NN ._. A_DT study_NN of_IN rhinoviral_NN shedding_VBG detected_VBN a_DT titer_NN
        of_IN at_IN least_JJS 1_CD ,_, 600_CD TCID_NNP 
        50_CD per_IN ml_NN of_IN nasopharngeal_NN wash_NN in_IN 17_CD
        out_IN of_IN 26_CD infected_JJ volunteers_NNS [_NN 35_CD ]_NN ._. So_IN it_PRP is_VBZ clear_JJ that_IN
        infected_JJ people_NNS can_MD produce_VB a_DT large_JJ amount_NN of_IN virus_NN ,_, but_CC it_PRP
        is_VBZ unknown_JJ how_WRB much_JJ of_IN that_DT virus_NN becomes_VBZ airborne_JJ through_IN
        coughs_NNS ,_, sneezes_NNS ,_, respiration_NN and_CC talking_VBG ._.
        Two_CD studies_NNS have_VBP attempted_VBN to_TO determine_VB the_DT infectious_JJ
        dose_NN 50_CD %_NN (_( ID_NNP 
        50_CD )_) of_IN rhinovirus_JJ for_IN humans_NNS [_NN 36_CD 37_CD ]_NN
        ._. The_DT ID_NNP 
        50_CD for_IN microorganisms_NNS depend_VBP on_IN at_IN least_JJS
        four_CD criteria_NNS :_: (_( 1_LS )_) the_DT strain_NN of_IN the_DT organism_NN ,_, (_( 2_LS )_) the_DT
        route_NN of_IN transmission_NN ,_, (_( 3_LS )_) the_DT method_NN of_IN inoculation_NN ,_, and_CC
        (_( 4_LS )_) host_NN immunity_NN ._. In_IN a_DT study_NN published_VBN in_IN 1966_CD ,_,
        investigators_NNS from_IN the_DT U_NNP ._. S_NNP ._. Army_NNP Biological_NNP Laboratories_NNPS
        and_CC the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP
        Disease_NNP ,_, conducted_VBD a_DT series_NN of_IN tests_NNS designed_VBN to_TO determine_VB
        if_IN respiratory_JJ viral_JJ agents_NNS were_VBD transmitted_VBN via_IN the_DT
        aerosol_NN route_NN ._. Using_VBG rhinovirus_JJ type_NN 15_CD ,_, they_PRP inoculated_JJ
        volunteers_NNS in_IN the_DT nose_NN with_IN both_DT nasal_NN drops_NNS and_CC an_DT aerosol_NN
        (_( particle_NN size_NN 0_CD ._. 3_CD to_TO 2_CD ._. 5_CD μm_NN )_) ._. The_DT authors_NNS estimated_VBD a_DT
        human_JJ ID_NNP 
        50_CD of_IN 0_CD ._. 032_CD TCID_NNP 
        50_CD for_IN nasal_NN drops_NNS and_CC 0_CD ._. 68_CD TCID_NNP 
        50_CD for_IN aerosols_NNS [_NN 36_CD ]_NN ._. In_IN a_DT study_NN
        conducted_VBN in_IN 1984_CD ,_, researchers_NNS inoculated_JJ volunteers_NNS with_IN
        rhinovirus_JJ type_NN 16_CD with_IN droplets_NNS of_IN viral_JJ suspension_NN in_IN
        several_JJ locations_NNS ._. The_DT authors_NNS determined_VBD the_DT ID_NNP 
        50_CD for_IN nasal_NN drops_NNS was_VBD 0_CD ._. 28_CD TCID_NNP 
        50_CD [_NN 37_CD ]_NN ._. If_IN we_PRP assume_VBP that_IN the_DT
        infectious_JJ dose_NN is_VBZ acquired_VBN through_IN an_DT aerosol_NN ,_, the_DT aerosol_NN
        data_NN from_IN 1966_CD suggests_VBZ that_IN our_PRP$ assay_NN can_MD detect_VB an_DT amount_NN
        approximately_RB equal_JJ to_TO twice_RB the_DT ID_NNP 
        50_CD in_IN humans_NNS ._. But_CC ,_, if_IN the_DT spiking_VBG
        experiment_NN is_VBZ a_DT better_JJR estimate_NN of_IN actual_JJ detection_NN limit_NN
        due_JJ to_TO the_DT inactivation_NN by_IN the_DT nebulizer_NN ,_, then_RB our_PRP$
        detection_NN limit_NN is_VBZ approximately_RB equal_JJ to_TO the_DT ID_NNP 
        50_CD ._.
        Caution_NN must_MD be_VB taken_VBN when_WRB interpreting_VBG results_NNS from_IN
        PCR-based_NNP air_NN samples_NNS ._. Nucleic_NNP acid_NN detection_NN methods_NNS ,_, such_JJ
        as_IN the_DT one_CD presented_VBN here_RB ,_, are_VBP capable_JJ of_IN detecting_VBG very_RB
        small_JJ quantities_NNS of_IN microorganisms_NNS ,_, but_CC these_DT techniques_NNS
        cannot_NN determine_VB if_IN the_DT microorganism_NN is_VBZ infectious_JJ at_IN the_DT
        time_NN of_IN detection_NN ._.
      
      
        Conclusions_NNP
        The_DT filter_NN collection_NN and_CC PCR-based_NNP detection_NN methods_NNS
        developed_VBN here_RB offers_VBZ some_DT clear_JJ advantages_NNS over_IN the_DT use_NN of_IN
        more_JJR traditional_JJ methods_NNS such_JJ as_IN impinger_NN collection_NN and_CC
        cell_NN culture_NN based_VBD detection_NN ._. The_DT use_NN of_IN filter_NN collection_NN
        allows_VBZ for_IN a_DT much_JJ longer_JJR sample_NN time_NN ,_, while_IN impingers_NNS
        cannot_NN be_VB used_VBN for_IN longer_JJR than_IN 15_CD -_: 20_CD minutes_NNS ._. As_IN was_VBD
        demonstrated_VBN here_RB ,_, filters_NNS can_MD be_VB used_VBN to_TO collect_VB at_IN least_JJS
        40_CD -_: hour_NN samples_NNS without_IN reduced_VBN ability_NN to_TO detect_VB virus_NN on_IN
        the_DT filter_NN ._. Cell_NNP culture_NN methods_NNS ,_, while_IN useful_JJ in_IN
        determining_VBG the_DT amount_NN of_IN infectious_JJ virus_NN ,_, could_MD not_RB be_VB
        used_VBN to_TO detect_VB the_DT very_RB low_JJ levels_NNS of_IN infectious_JJ virus_NN
        present_JJ in_IN room_NN air_NN because_IN collection_NN of_IN viable_JJ virus_NN over_IN
        long_JJ sampling_VBG times_NNS is_VBZ not_RB currently_RB feasible_JJ ._. Therefore_RB ,_,
        the_DT use_NN of_IN filter_NN collection_NN and_CC PCR_NNP based_VBD detection_NN is_VBZ the_DT
        only_JJ method_NN presently_RB available_JJ to_TO detect_VB low_JJ
        concentrations_NNS of_IN respiratory_JJ virus_NN in_IN air_NN ._. However_RB ,_, at_IN UV_NNP
        doses_NNS much_RB higher_RBR than_IN typically_RB used_VBN in_IN upper_JJ room_NN UV_NNP
        applications_NNS ,_, this_DT method_NN was_VBD unable_JJ to_TO distinguish_VB between_IN
        UV_NNP irradiated_JJ aerosols_NNS and_CC nonexposed_JJ aerosols_NNS ._.
      
      
        Abbreviations_NNP
        PBS_NNP -_: Phosphate_NNP buffered_JJ saline_NN
        MMD_NNP -_: Mass-median_NNP diameter_NN
        RT-PCR_NNP -_: Reverse-transcriptase_NNP polymerase_NN chain_NN
        reaction_NN
        TCID_NNP 50_CD -_: Tissue_NNP culture_NN infectious_JJ dose_NN 50_CD %_NN
        UVGI_NNP -_: Ultraviolet_NNP germicidal_NN irradiation_NN
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD
      
      
        Authors_NNP '_'' contributions_NNS
        TM_NNP participated_VBD in_IN the_DT study_NN design_NN ,_, the_DT modification_NN of_IN
        the_DT chamber_NN ,_, and_CC performed_VBD the_DT aerosol_NN experiments_NNS and_CC
        molecular_JJ assays_NNS ._. SJ_NNP participated_VBD in_IN development_NN of_IN the_DT
        molecular_JJ assays_NNS and_CC study_NN design_NN ._. SR_NNP participated_VBD in_IN the_DT
        design_NN of_IN the_DT study_NN and_CC modification_NN of_IN the_DT chamber_NN ._. DM_NNP
        participated_VBD in_IN study_NN design_NN and_CC coordination_NN of_IN the_DT
        study_NN ._.
      
    
  
